The PPARγ-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction
Open Access
- 1 June 2003
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 58 (3) , 632-637
- https://doi.org/10.1016/s0008-6363(03)00289-x
Abstract
Objective: Peroxisome proliferator-activated receptor γ (PPARγ) activators may be beneficial in heart failure due to their metabolic and antihypertroKeywords
This publication has 0 references indexed in Scilit: